About Ben Liu
Ben Liu is the CEO and Co-Founder of a company focused on developing diagnostics and therapeutics for Parkinson’s and Alzheimer’s disease using AI and big data.
Known information
Ben Liu, CEO and Co-Founder, has an impressive academic background with a DPhil from Oxford as a Rhodes Scholar and an MPhil with distinction in Computational Biology from Cambridge as a Paul Mellon Fellow. He graduated from Yale, receiving the college’s highest honor at graduation. Liu has effectively leveraged machine learning, artificial intelligence, and big data to advance diagnostics and therapeutics for neurological diseases such as Parkinson’s and Alzheimer’s. Additionally, he contributes his expertise as an advisor to the Harvard Business School’s MS/MBA Program in Biotechnology.
About Trial Spark
Trial Spark is a tech-driven company that accelerates the development of clinical-stage drugs by leveraging its proprietary platform, focusing on efficiency without compromising quality and safety.